Chinese General Practice

    Next Articles

Interpretation of the Reporting Guideline for Systematic Reviews of Outcome Measurement Instruments (PRISMA-COSMIN for OMIs 2024)

  

  1. 1.The First Affiliated Hospital of Henan University of Chinese Medicine,Zhengzhou 450000,China;2.Evidence-Based Social Science Research Center,School of Public Health,Lanzhou University,Lanzhou 730000,China;3.Henan University of Chinese Medicine,Zhengzhou 450046,China;4.Jianshi County Chinese Medicine Hospital,Enshi 445300,China;5.Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China
  • Received:2024-09-06 Accepted:2024-10-16
  • Contact: ZHAO Wenxia,Professor;E-mail:wenxia-zhao@163.com;LU Cuncun;E-mail:lu17metrics@163.com

结局测量工具系统评价的报告规范(PRISMA-COSMIN for OMIs 2024)解读

  

  1. 1.450000 河南省郑州市,河南中医药大学第一附属医院;2.730000 甘肃省兰州市,兰州大学公共卫生学院循证社会科学研究中心;3.450046 河南省郑州市,河南中医药大学;4.445300 湖北省恩施土家族苗族自治州,建始县中医医院;5.100700 北京市,中国中医科学院中医临床基础医学研究所
  • 通讯作者: 赵文霞,教授;E-mail:wenxia-zhao@163.com;卢存存;E-mail:lu17metrics@163.com
  • 基金资助:
    河南省中医药科学研究专项课题(2024ZY2046);河南省中医学“双一流”创建科学研究专项(STG-ZYX02-202117、HSRP-DFCTCM-2023-4-02);河南省科技研发计划联合基金(优势学科培育类)项目(242301420112)

Abstract: Outcome Measurement Instruments(OMI)are essential tools for evaluating patients’ experiences or health status,but their quality levels often vary. The COnsensus-based Standards for the selection of health Measurement INstruments(COSMIN)provide methodological guidance for selecting high-quality OMIs,which is widely recognized. In recent years,there has been a sharp increase in the number of systematic reviews of OMI based on COSMIN. However,many published related systematic reviews often fail to fully report key information,significantly impacting the reproducibility and interpretability of such systematic reviews,thus affecting the dissemination and application of their results. As the PRISMA 2020 does not include all necessary information for reporting such systematic reviews,the scholars have developed a new reporting standard,“PRISMA-COSMIN for OMIs 2024”,to assist researchers in writing and reporting systematic reviews of OMI in a clear,detailed,and transparent manner. This article introduces and interprets this guideline through an example paper,aiming to help domestic scholars better understand and effectively apply the guideline,thereby enhancing the overall quality of systematic reviews of OMI conducted in China.

Key words: Patient reported outcome measures, Health outcome, Outcome measurement instrument, COnsensus-based Standards for the selection of health Measurement INstruments, Systematic review, Reporting guideline

摘要: 结局测量工具(OMI)是评估患者感受或健康状况的重要工具,但其质量层次不齐。选择健康测量工具的共识标准(COSMIN)为遴选高质量的 OMI 提供了方法学指导,得到广泛认可。近年来,基于 COSMIN 开展的OMI 系统评价数量激增,然而许多已发表的相关系统评价常未能充分报告关键信息,严重影响了 OMI 系统评价的可重复性和可解释性,从而影响其结果的推广应用。鉴于 PRISMA 2020 未包含报告此类系统评价的所有必要信息,有关学者在前者基础上制定了新的报告规范“PRISMA-COSMIN for OMIs 2024”,以帮助研究人员以清晰、详细和透明的方式撰写和报告 OMI 系统评价。本文结合实例对该规范进行了介绍和解读,旨在帮助国内学者深入理解并有效应用该指南,提高国内 OMI 系统评价的整体质量。

关键词: 患者报告结局评价, 健康结局, 结局测量工具, 选择健康测量工具的共识标准, 系统评价, 报告规范

CLC Number: